Final Program

216 MONDAY • MAY 16
and a number of basic and translational scientists who contributed greatly in
our understanding of basic mechanisms by which tear gas and chlorine damage
the cardiopulmonary systems.
Chairing: S. Matalon, PhD, Birmingham, AL
2:15 Introduction
E. Summerhill, MD, Pawtucket, RI
2:20 Pulmonary and Systemic Consequences of Tear Gas Exposure
in an Urban Turkish Population
E. Dagli, MD, Istabul, Turkey
2:40 Chemosensation and Reflex Control in Inhalational Exposures
S.E. Jordt, PhD, Durham, NC
3:00 Mechanisms and Modification of Chlorine and Other Halogen
Gas Induced Injury
S. Matalon, PhD, Birmingham, AL
3:15 Graniteville, SC Railway Derailment: Acute and Chronic Effects
of Chlorine Gas Exposure
E.R. Svendsen, PhD, Charleston, SC
3:35 Managing Chemical Disasters Across the Globe: A Doctor
Without Borders Perspective
F. Baud, MD, Paris, France
3:55 Novel Countermeasures for Inhalational Exposures: Is There
Hope on the Horizon?
C.W. White, MD, Denver, CO
B90
BASIC
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
NEW INSIGHTS INTO THE PREDISPOSITION,
PATHOGENESIS, AND MANAGEMENT OF FUNGAL
PNEUMONIA
Assemblies on Microbiology, Tuberculosis and Pulmonary Infections;
Allergy, Immunology and Inflammation; Critical Care; Respiratory Cell
and Molecular Biology
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3016/3018 (West Building, Level 3)
Target Audience
Basic or clinical translational scientists interested in learning about the latest
advances in the field of respiratory fungal diseases; clinicians seeking to
update their knowledge on the management of immune suppressed or
immune competent patients with endemic or opportunistic fungal pneumonia.
Objectives
At the conclusion of this session, the participant will be able to:
• learn new findings about the genetic defects and other immune factors that
predispose the host to develop fungal pneumonia;
• apply new knowledge about the molecular and cellular mechanisms that
underlie the pathophysiology of fungal pneumonia;
• diagnose and integrate new treatment options for fungal pneumonia.
This session will provide attendees with a state of the art review of emerging
scientific principles and clinically relevant advances that are pertinent to the
understanding of invasive fungal infection of the respiratory system. Individual
speakers will describe novel primary immune deficiencies that predispose certain
individuals to fungal pneumonia as well as the systems biology approach to
comprehensively understand fungal-host cell interactions. Recent insights molecular
and cellular pathogenesis of endemic and opportunistic fungal pneumonias will then
be considered. Finally, the latest advances in clinical diagnostic strategies and
therapeutic approaches for respiratory fungal diseases will be reviewed.
Chairing: S. Qureshi, MD, Montreal, Canada
S.E. Evans, MD, Houston, TX
C.S. Dela Cruz, MD, PhD, New Haven, CT
2:15 Primary Immunodeficiencies Underlying Respiratory Fungal
Infection
A. Puel, PhD, Paris, France
2:35 Systems Biology Analysis of the Fungal-Host Cell Interaction
L. Romani, MD, PhD, Perugia, Italy
2:55 Pathogenesis of Opportunistic Fungal Pneumonia
A.H. Limper, MD, Rochester, MN
3:15 Subversion of Host Immunity by Endemic Fungal Pathogens
S. Qureshi, MD, Montreal, Canada
3:35 Novel Diagnostic Tools and Approaches to Fungal Pneumonia
C.A. Hage, MD, Indianapolis, IN
3:55 Current Therapeutic Approaches for Fungal Pneumonia
S.E. Evans, MD, Houston, TX
B91
There will be a 5-minute discussion after each talk.
BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
AJRCCM: LEADING JOURNAL IN RESPIRATORY,
CRITICAL CARE AND SLEEP MEDICINE. KEY
PAPERS, PUBLICATION ETHICS, NEW INITIATIVES
AJRCCM; Assemblies on Allergy, Immunology and Inflammation;
Behavioral Science and Health Services Research; Clinical Problems;
Critical Care; Environmental, Occupational and Population Health;
Microbiology, Tuberculosis and Pulmonary Infections; Nursing;
Pediatrics; Pulmonary Circulation; Pulmonary Rehabilitation;
Respiratory Cell and Molecular Biology; Respiratory Structure and
Function; Sleep and Respiratory Neurobiology; Thoracic Oncology
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 2002/2004 (West Building, Level 2)
Target Audience
All readers and potential authors of AJRCCM, and early career researchers in
particular.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the scope of the ATS family of journals and what makes a good
and acceptable paper;
ATS 2016 • San Francisco